Development and validation of a lung metastases-predicting nomogram for intermediate- to high-risk differentiated thyroid carcinoma patients

被引:1
|
作者
Ma, Wenhui [1 ]
Yu, Feng [1 ]
Chen, Bowen [1 ]
Yang, Zhiping [1 ]
Kang, Fei [1 ]
Li, Xiang [1 ]
Yang, Weidong [1 ]
Wang, Jing [1 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Nucl Med, 127, Changle West Rd, Xian 710000, Shaanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
calibration curve; DCA curve; differentiated thyroid carcinoma; early diagnosis; lung metastases; nomogram; prediction model; prognosis; radioiodine therapy; ROC curve; SERUM THYROGLOBULIN LEVELS; PROGNOSTIC-FACTORS; BRAF(V600E) MUTATION; DISTANT METASTASES; STIMULATED THYROGLOBULIN; PULMONARY METASTASIS; RADIOIODINE THERAPY; CANCER; PAPILLARY; ASSOCIATION;
D O I
10.1080/14796694.2024.2354161
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: This research aimed to construct a clinical model for forecasting the likelihood of lung metastases in differentiated thyroid carcinoma (DTC) with intermediate- to high-risk. Methods: In this study, 375 DTC patients at intermediate to high risk were included. They were randomly divided into a training set (70%) and a validation set (30%). A nomogram was created using the training group and then validated in the validation set using calibration, decision curve analysis (DCA) and receiver operating characteristic (ROC) curve. Results: The calibration curves demonstrated excellent consistency between the predicted and the actual probability. ROC analysis showed that the area under the curve in the training cohort was 0.865 and 0.845 in the validation cohort. Also, the DCA curve indicated that this nomogram had good clinical utility. Conclusion: A user-friendly nomogram was constructed to predict the lung metastases probability with a high net benefit.
引用
收藏
页码:1575 / 1586
页数:12
相关论文
共 50 条
  • [1] Development and validation of a lung metastasis-predicting Nomogram for intermediate- to high-risk differentiated thyroid carcinoma patients
    Yu, Feng
    Ma, Wenhui
    Yang, Zhiping
    Yang, Weidong
    Wang, Jing
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [2] Development and validation of a lung metastasispredicting Nomogram for intermediate- to high-risk differentiated thyroid carcinoma patients
    Yu, F.
    Wang, J.
    Yang, W.
    Yang, Z.
    Ma, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S667 - S667
  • [3] Development and validation of a nomogram for predicting survival in intermediate- and high-risk neuroblastoma of the Children's Oncology Group risk stratification
    Feng, Lijuan
    Kan, Ying
    Wang, Wei
    Wang, Chao
    Zhang, Hui
    Xie, Peng
    Yang, Jigang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (18) : 16377 - 16390
  • [4] Development and validation of a nomogram for predicting survival in intermediate- and high-risk neuroblastoma of the Children's Oncology Group risk stratification
    Lijuan Feng
    Ying Kan
    Wei Wang
    Chao Wang
    Hui Zhang
    Peng Xie
    Jigang Yang
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 16377 - 16390
  • [5] Low-dose radioiodine therapy for patients with intermediate- to high-risk differentiated thyroid cancer
    Abe, Koichiro
    Ishizaki, Umiko
    Ono, Toshihiro
    Horiuchi, Kiyomi
    Kanaya, Kazuko
    Sakai, Shuji
    Okamoto, Takahiro
    ANNALS OF NUCLEAR MEDICINE, 2020, 34 (02) : 144 - 151
  • [6] Low-dose radioiodine therapy for patients with intermediate- to high-risk differentiated thyroid cancer
    Koichiro Abe
    Umiko Ishizaki
    Toshihiro Ono
    Kiyomi Horiuchi
    Kazuko Kanaya
    Shuji Sakai
    Takahiro Okamoto
    Annals of Nuclear Medicine, 2020, 34 : 144 - 151
  • [7] Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid Cancer
    Klubo-Gwiezdzinska, Joanna
    Auh, Sungyoung
    Gershengorn, Marvin
    Daley, Brianna
    Bikas, Athanasios
    Burman, Kenneth
    Wartofsky, Leonard
    Urken, Mark
    Dewey, Eliza
    Smallridge, Robert
    Chindris, Ana-Maria
    Kebebew, Electron
    JAMA NETWORK OPEN, 2019, 2 (02) : e187754
  • [8] Impact of delayed radioiodine therapy in intermediate-/high-risk papillary thyroid carcinoma
    Kim, Mijin
    Han, Minkyu
    Jeon, Min Ji
    Kim, Won Gu
    Kim, In Joo
    Ryu, Jin-Sook
    Min, Won Bae
    Shong, Young Kee
    Kim, Tae Yong
    Kim, Bo Hyun
    CLINICAL ENDOCRINOLOGY, 2019, 91 (03) : 449 - 455
  • [9] Analysis of risk factors of lung metastases in patients with differentiated thyroid carcinoma
    Chen, Pan
    Ouyang, Wei
    Feng, Huijuan
    Sun, Yungang
    Wu, Juqing
    Wang, Jing
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [10] Incomplete response to therapy in intermediate- and high-risk thyroid cancer
    Ali S. Alzahrani
    Noha Mukhtar
    Endocrine, 2022, 78 : 531 - 542